(A) Axial and (B) coronal reformatted images from CT performed with IV contrast material show segmental visualization of main pancreatic duct (arrow). One of three reviewers described main duct dilation as present. Agreement among reviewers on CT for main duct dilatation was substantial (κ=0.63).

March 9, 2022 — According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR), interobserver agreement proved generally fair to moderate for most CT and MRI findings of chronic pancreatitis in children.

“This study highlights challenges for the imaging diagnosis of pediatric chronic pancreatitis,” wrote first author Andrew T. Trout of Cincinnati Children's Hospital Medical Center in Ohio. “Standardized and/or objective criteria are needed, given the importance of imaging in diagnosis.”

In Trout et al.’s retrospective study, CT or MRI examinations performed in children with chronic pancreatitis were submitted by six sites participating in the INternational Study Group of Pediatric Pancreatitis: In search for a cuRE (INSPPIRE) consortium. One board-certified pediatric radiologist from each of the six sites participated in independent image review. Three radiologists independently reviewed only CT examinations, whereas three other radiologists independently reviewed just MRI examinations. While measuring pancreas thickness and duct diameter, reviewers evaluated 13 categorical subjective features: 12 on both CT and MRI, 1 on CT only, 1 on MRI only.

In this study of six sites in the INSPPIRE consortium, interobserver agreement for findings of chronic pancreatitis in children was relatively high for CT for the presence of parenchymal calcifications (κ=0.81), pancreatic duct dilation (κ=0.63), and atrophy (κ=0.52); and for MRI for main and side branch pancreatic duct findings (κ=0.64-0.74).

Noting that duct findings showed the highest levels of agreement for both modalities, “agreement for subjective findings of atrophy was moderate, and agreement for parenchymal thickness (a quantitative measure of atrophy) depended on the location of measurement, with the best agreement observed in the pancreatic body,” the authors of this AJR article concluded.

For more information: www.arrs.org


Related Content

News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
News | ACR

April 15, 2023 — The American College of Radiology (ACR) released an update to its ACR Appropriateness Criteria (ACR AC) ...

Time April 13, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 10, 2024 — Online MRI and CT education leader, ImagingU, announced the launch of a new course for students and ...

Time April 10, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
News | Radiation Dose Management

April 9, 2024 — Mirion Dosimetry Services, a Mirion Medical company, today announced commercial availability of its ...

Time April 09, 2024
arrow
Subscribe Now